Filing Details

Accession Number:
0001209191-23-002414
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-06 17:23:40
Reporting Period:
2023-01-04
Accepted Time:
2023-01-06 17:23:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1652130 Intellia Therapeutics Inc. NTLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1581992 Glenn Goddard C/O Intellia Therapeutics, Inc.
40 Erie Street; Suite 130
Cambridge MA 02139
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-04 2,427 $37.21 15,404 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023.